<DOC>
	<DOCNO>NCT00369148</DOCNO>
	<brief_summary>Combination therapy glinides premixed insulin provide good glycemic control premixed insulin alone .</brief_summary>
	<brief_title>Combination Glinides With Premixed Insulin</brief_title>
	<detailed_description>Type 2 diabetic patient undergoing twice daily injection premixed insulin administer glinides ( 10mg mitiglinide 90 mg nateglinide ) lunchtime without change insulin regimen . Twelve week administration glinides , discontinue . HbA1c level start glinide administration , 12 week administration , 12 week discontinuation measure .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Nateglinide</mesh_term>
	<mesh_term>Mitiglinide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Clinical diagnosis type 2 diabetes Who undergo twice daily injection premixed insulin Whose HbA1c 6.5 % le 8.0 % Whose change HbA1c 1.0 % 12 week observational period</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>glinides</keyword>
	<keyword>premixed insulin</keyword>
	<keyword>combination therapy</keyword>
	<keyword>glycemic control</keyword>
</DOC>